April 30, 2025From IOB to DANDRITE: Fiona Müllner appointed as new Group LeaderFiona Müllner, currently a postdoctoral researcher at IOB, has been appointed Group Leader at DANDRITE, the Danish Research Institute of Translational Neuroscience, and Associate Professor at Aarhus University.
April 16, 2025Key discoveries in myopia research: A 50-year journeyFrom retinal signals to environmental factors - Frank Schaeffel’s new paper charts five decades of discoveries shaping the way we understand and manage myopia.
April 15, 2025Uncovering the genetic roots of blindness: A landmark study in PakistanAn international team led by IOB researchers has conducted the most extensive genetic study of inherited retinal diseases in Pakistan to date. The findings, now published in npj Genomic Medicine, shed light on unique mutational patterns shaped by consanguinity and population structure, offering vital insights for diagnosis and future therapies.
March 21, 2025Brain's efficiency emerges from randomnessAn international research collaboration, including IOB scientists, reveals that the brain's remarkable efficiency doesn't require precise fine-tuning – it can emerge naturally from random patterns of neural activity.
March 12, 2025Three novel disease genes identified as drivers of a new form of hereditary retinal blindnessIOB researchers reveal the genetic basis of lysosomal macular dystrophy, an uncharacterized inherited retinal condition, opening new avenues for diagnosis and potential therapies.
February 24, 2025Hidden order in the brain's GPSRava Azeredo da Silveira and collaborators have revealed a surprisingly simple mathematical principle that explains how brain cells create mental maps across different species and environments.
February 11, 2025The secret behind sharp visionIOB researchers reveal how tiny, involuntary eye movements, rather than impairing our vision, actually help us see fine details more clearly by optimizing how our retinas process visual information.
January 10, 2025IOB's first spinout RhyGaze receives major fundingFounded on IOB's pioneering research in optogenetic vision restoration, RhyGaze draws substantial Series A investment to advance novel gene therapy for treating blindness.
January 08, 2025Rewriting genes to preserve eyesightIOB researchers have achieved a significant advance in developing a new treatment for Stargardt disease, the most common form of inherited macular degeneration. The groundbreaking study, published in Nature Medicine, paves the way for potential treatment of Stargardt disease and other inherited retinal disorders.
December 31, 2024IOB's Winter Highlights 2024As winter brings snow to the Alps, our team at IOB continues its research in vision science. In these past months of 2024, our research community has maintained its strong commitment to understanding vision and developing new therapies for vision loss.
October 01, 2024IOB researchers discover new gene linked to inherited blindnessA study led by IOB scientists from the Rivolta Lab uncovers a surprising connection between a gene involved in energy production and a form of hereditary vision loss.
September 23, 2024IOB scientists solve a 50-year-old vision mysteryResearchers at IOB have discovered a surprisingly simple mechanism behind the first step of visual processing, solving a decades-old puzzle in neuroscience.
September 21, 2024Two IOB scientists receive the Swiss OphthAward 2024Congratulations to Mathieu Quinodoz and Fiona Müllner who both won the Swiss OphthAward 2024.
July 17, 2024IOB’s first spinout: RhyGaze AGSix years after its foundation, IOB introduces its first spinout company, RhyGaze AG, which will focus on advancing groundbreaking gene therapy to treat blindness.
July 12, 2024Swiss national MD-PhD grants to two IOB scientistsWe are excited to announce that Jay Zoellin (left) and Dr. Stefan Futterknecht (right) have each been awarded the prestigious National MD-PhD Grant by the Swiss Academy of Medical Sciences (SAMS) and the Swiss National Science Foundation.
July 08, 2024IOB Group Leader Dr. Andreas Keller appointed Associate Professor at the University of BaselWarm congratulations to Andreas Keller, wo has been named Professor of Physiology at the Faculty of Medicine. He will take up his position at the Department of Biomedicine on August 1, 2024.